PAR
Click for more information
3.57% 29.0¢ paradigm biopharmaceuticals limited..

Nice reminder Dungiven. It does make me wonder too what the...

  1. Torpy
    1,559 Posts.
    lightbulb Created with Sketch. 619
    clock Created with Sketch.
    15/03/23
    10:32
    Post #: 66772763
    Nice reminder Dungiven.
    It does make me wonder too what the angle is with this work as PAR are potentially the biggest beneficiary of the review (independent summary of PPS validating many of its mechanisms and highlighting the potential depth of the pipeline, a great read for a potential partner!).
    These statements at the bottom appear to distance Arthropharm from the work itself.

    Funding

    This study was funded by The Melrose Personal Research Fund, Sydney, Australia.

    Acknowledgments

    J.M. has received consultancy fees from Arthropharm Pharmaceuticals Pty Ltd. M.M.S. is a clinical research director at Arthropharm Pharmaceuticals Pty Ltd. That company was not involved in the design and interpretation of this review or in the decision to publish this information.

    Last edited by Torpy: 15/03/23
    PAR Price at posting: $1.39 Sentiment: None Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.0¢ 		Change
0.010(3.57%) 		Mkt cap ! $97.94M
Open High Low Value Volume
28.0¢ 29.5¢ 28.0¢ $69.85K 245.6K

Buyers (Bids)

No. Vol. Price($)
2 1898 30.5¢
 

Sellers (Offers)

Price($) Vol. No.
28.5¢ 1410 1
View Market Depth
Last trade - 15.59pm 03/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.